INmune Bio (INMB) Research Hub

INmune Bio (INMB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.43 USD (-2.05%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.09, market cap 0.05B. This hub links to the full technical, earnings and options research available for INMB.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close1.43 USD (-2.05%)
52-week range1.25 USD – 2.6 USD
Trend regimeRange
14-day RSI22.5 (Oversold)
Trailing P/E-1.09
Market cap0.05B
Dividend yield0.00%
Next earnings2026-08-06

Available research for INMB

Earnings

INMB earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -1.09. Updated 2026-07-23.

Options: Covered Call

Covered Call on INMB: how it works, illustrative setup around the real 1.43 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on INMB: how it works, illustrative setup around the real 1.43 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on INMB: how it works, illustrative setup around the real 1.43 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

INMB technical analysis: range, last 1.43 USD, RSI 22.5, 52w range 1.25 USD–2.6 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is INMB in?

INmune Bio (INMB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is INMB in an uptrend or downtrend?

As of 2026-10-26, INMB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is INMB's trailing P/E ratio?

INMB's trailing P/E is -1.09, with a market cap of 0.05B. See the earnings research page for full valuation detail.

When does INMB next report earnings?

INMB is next scheduled to report earnings on 2026-08-06.